# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA981160 | B | Inhibition of Human enterovirus 71 TW/2231/98 recombinant protease 3C expressed in Escherichia coli JM109 competent cells | Enterovirus A71 | 11 | ALA1155789 | cell-based format | Scientific Literature | |
2. | ALA981162 | F | Antiviral activity against Human enterovirus 71 in human rhabdomyosarcoma cells assessed as virus-induced cell death after 72 hrs | Enterovirus A71 | 11 | ALA1155789 | organism-based format | Scientific Literature | |
3. | ALA981163 | A | Cytotoxicity against human RD cells | Homo sapiens | 11 | ALA1155789 | cell-based format | Scientific Literature | |
4. | ALA3743963 | B | Inhibition of EV71 protease 3C using NMA-IEALFQGPPK(DNP)FR as substrate preincubated for 30 mins followed by substrate addition measured after 2 hrs by FRET analysis | Enterovirus A71 | 14 | ALA3739383 | assay format | Scientific Literature | |
5. | ALA3743964 | A | Cytotoxicity against human Rhabdomyosarcoma cells after 24 hrs by WST-1 cell proliferation assay | Homo sapiens | 14 | ALA3739383 | cell-based format | Scientific Literature | |
6. | ALA3743965 | F | Antiviral activity against EV71 pseudotype virus infected in human Rhabdomyosarcoma cells assessed as reduction in viral replication after 24 hrs by Bright-Glo Luciferase Assay | Enterovirus A71 | 14 | ALA3739383 | organism-based format | Scientific Literature | |
7. | ALA5039228 | F | Antiviral activity against wild type Rhinovirus-A02 infected in HeLa cells assessed as reduction in virus-induced cytopathic effect incubated for 3 days by MTS/PMS assay | Rhinovirus | 4 | ALA5038578 | cell-based format | Scientific Literature | |
8. | ALA5039229 | F | Antiviral activity against wild type Human rhinovirus B14 infected in HeLa cells assessed as reduction in virus-induced cytopathic effect incubated for 3 days by MTS/PMS assay | rhinovirus B14 | 4 | ALA5038578 | organism-based format | Scientific Literature | |
9. | ALA5039230 | B | Inhibition of Human enterovirus 71 3C-like protease expressed in Escherichia coli BL21 (DE3) cells using Dacyl-KTSAVLQSGFRKMEEdans as fluorogenic substrate incubated for 10 mins by FRET assay | Enterovirus A71 | 24 | ALA5038578 | cell-based format | Scientific Literature | |
10. | ALA5039231 | F | Antiviral activity against Human enterovirus 71 BrCr infected in human RD cells assessed as reduction in virus-induced cytopathic effect incubated for 4 days by MTS/PMS assay | Enterovirus A71 | 24 | ALA5038578 | organism-based format | Scientific Literature | |
11. | ALA5039232 | T | Cytotoxicity against human RD cells assessed as reduction in cell viability measured after 4 days by MTS/PMS assay | Homo sapiens | 24 | ALA5038578 | cell-based format | Scientific Literature | |
12. | ALA5039233 | F | Antiviral activity against Human enterovirus 68 infected in HeLa cells assessed as reduction in virus-induced cytopathic effect incubated for 4 days by MTS/PMS assay | enterovirus D68 | 4 | ALA5038578 | organism-based format | Scientific Literature | |
13. | ALA5039234 | F | Antiviral activity against Human coxsackievirus A21 infected in HeLa cells assessed as reduction in virus-induced cytopathic effect incubated for 3 days by MTS/PMS assay | Coxsackievirus A21 | 4 | ALA5038578 | organism-based format | Scientific Literature | |
14. | ALA5039235 | F | Antiviral activity against Human coxsackievirus B3 infected in Vero cells assessed as reduction in plaque formation treated 2 hrs post viral infection and measured 3 to 4 days post-infection by Giemsa staining based plaque reduction assay | Coxsackievirus B3 | 4 | ALA5038578 | organism-based format | Scientific Literature |